Understanding Intervertebral Disc Degeneration
Intervertebral disc degeneration, often called IVDD, occurs when the discs between the bones of the spine begin to lose structure, hydration, and function. These discs act as cushions that help absorb shock, support movement, and maintain flexibility in the spine.
As degeneration progresses, the inner portion of the disc, known as the nucleus pulposus, may lose water and important structural components. This can contribute to inflammation, reduced disc height, pain signaling, and lower back discomfort. Current treatments often focus on managing symptoms through physical therapy, medication, injections, or surgery in more advanced cases. However, these approaches may not fully restore the biological health of the disc itself.
Because of this, researchers are studying regenerative strategies that may help support the disc environment and encourage repair at the cellular level.
Why Researchers Are Studying hUC-MSC-Derived EVs
Human umbilical cord mesenchymal stem cells, or hUC-MSCs, are widely studied in regenerative medicine because they release signals that may influence inflammation, immune activity, and tissue repair. One important part of this signaling process involves extracellular vesicles, or EVs.
EVs are tiny particles released by cells that carry proteins, lipids, and genetic material. They act as messengers, helping cells communicate with each other. Instead of using whole stem cells, EVs offer a cell-free approach that may still deliver many of the beneficial signaling effects associated with MSCs.
For disc degeneration, hUC-MSC-derived EVs are being studied for their potential to:
- Reduce inflammatory and pain-related signaling
- Support nucleus pulposus cell activity
- Encourage disc matrix repair
- Improve hydration and glycosaminoglycan content
- Promote a more repair-supportive disc environment
Study Overview
In this 2025 preclinical study, researchers examined whether extracellular vesicles derived from human umbilical cord MSCs could help improve intervertebral disc degeneration in a rat model.
The researchers created disc degeneration using a needle puncture model in rat tail discs. They then compared the effects of implanted hUC-MSCs and hUC-MSC-derived EVs. The goal was to evaluate whether EVs could remain in the injured disc, interact with local disc cells, and influence markers related to inflammation, pain, and tissue repair.
The study also looked at important features of disc health, including water content, glycosaminoglycan levels, and expression of cartilage-supportive markers.
Key Findings
The results showed that hUC-MSC-derived EVs had encouraging regenerative effects in the disc degeneration model.
Researchers found that the EVs were retained within the injured discs and were taken up by nucleus pulposus cells. This is important because nucleus pulposus cells help maintain the inner structure and hydration of the disc.
Compared with untreated degenerative discs, EV-treated discs showed increased expression of several markers connected to tissue repair and disc matrix health, including SOX9, TGFβ1, TGFβ2, and COL2. These markers are associated with cartilage-like tissue support, type II collagen production, and extracellular matrix regulation.
The study also found that EV-treated discs had higher glycosaminoglycan, or GAG, content. GAGs help the disc retain water, which is essential for cushioning and flexibility. Water content also improved, with EV-treated discs showing a greater increase in hydration compared with discs treated with hUC-MSCs.
In addition, EV treatment helped reduce several inflammatory and pain-related markers, including COX-2, CXCL-1, PPT-A, MMP-13, and YKL-40. These findings suggest that hUC-MSC-derived EVs may help shift the disc environment away from inflammation and tissue breakdown and toward repair.
How hUC-MSC-Derived EVs May Support Disc Repair
Disc degeneration is not only caused by mechanical wear and tear. Inflammation, oxidative stress, matrix breakdown, reduced hydration, and changes in nucleus pulposus cell function all contribute to the process.
This study suggests that hUC-MSC-derived EVs may support disc repair in several ways. First, they may help reduce inflammatory and pain-related signaling, which can contribute to ongoing tissue damage. Second, they may encourage local disc cells to produce more repair-supportive matrix components, such as type II collagen. Third, they may help restore hydration and GAG content, both of which are important for normal disc function.
Together, these effects suggest that EVs may influence the biological environment of the disc rather than only addressing symptoms.
Why This Research Matters
This study is meaningful because it highlights the potential of a cell-free regenerative approach for spine-related conditions. Instead of relying on whole-cell therapy, hUC-MSC-derived EVs may offer a way to deliver repair-supportive signals directly into the damaged disc environment.
The findings also add to the growing interest in extracellular vesicles as natural messengers in regenerative medicine. Their ability to communicate with local cells, regulate inflammation, and support tissue repair makes them an important area of continued research.
For intervertebral disc degeneration, this type of research may help guide future approaches focused on protecting disc structure, improving hydration, and supporting healthier spine function.
Limitations and Future Directions
Although the findings are promising, this was a preclinical animal study. The results were observed in a rat model, so more research is needed before these findings can be applied to human patients.
Future studies will need to evaluate long-term safety, ideal dosing, delivery methods, durability of results, and whether similar benefits can be seen in larger animal models and clinical trials.
Conclusion
This study provides encouraging preclinical evidence that extracellular vesicles derived from human umbilical cord MSCs may support repair in intervertebral disc degeneration. In the rat model, hUC-MSC-derived EVs were associated with improved disc hydration, increased repair-related markers, greater GAG content, and reduced inflammatory and pain-related gene activity.
While more research is needed, these findings highlight the growing potential of EV-based regenerative strategies for disc health and spine repair.
Source
Ekram S, Ramzan F, Salim A, Durrieu MC, Khan I. Extracellular Vesicles Derived from Human Umbilical Cord-Mesenchymal Stem Cells Ameliorate Intervertebral Disc Degeneration. Biomedicines. 2025 Oct 3;13(10):2420. doi: 10.3390/biomedicines13102420. PMID: 41153707; PMCID: PMC12561700. Available from: https://www.mdpi.com/2227-9059/13/10/2420
Related Treatment Pages